| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |